Hepatitis C News

In 2015, WHO initiated a campaign to eliminate hepatitis B and C worldwide.

Hepatitis C reinfection rates were high among a population of people who had experienced homelessness but increased even more among those experiencing homelessness at the time of treatment, researchers found.

Testing for HIV, hepatitis B, and hepatitis C increased among U.S. Medicaid enrollees initiating treatment for opioid use disorder. However, a recent study showed approximately three-quarters of enrollees were not tested for each condition.

WASHINGTON — Active IV or prescription drug use did not affect attainment of sustained virologic response when treatment adherence for hepatitis C virus was already variable, according to a poster presented at The Liver Meeting.

Direct-acting antiviral treatment significantly lowered the risk for mortality and liver and non-liver outcomes in patients with chronic hepatitis C virus infection, regardless of disease stage, researchers reported.

Less than two-thirds of insured patients with viremic hepatitis C virus infection received treatment with direct-acting antivirals from 2014 to 2021, with a sharp decline in diagnoses and treatment reported during the COVID-19 pandemic.

WASHINGTON — In this video, Norah Terrault, MD, MPG, FAASLD, chief of gastroenterology and liver diseases at the University of Southern California Keck School of Medicine, discusses a national strategy to eliminate hepatitis C virus.

WASHINGTON — A leading expert in hepatology called for fellow specialists to embrace a role of education, advocacy and support as part of a proposed national hepatitis C virus elimination program presented during The Liver Meeting.

WASHINGTON — Vosevi, a triple-combination therapy for chronic hepatitis C virus infection, was effective when used as a rescue treatment in patients who did not achieve sustained virologic response with direct-acting antiviral agents.

WASHINGTON — In this video, John Ward, MD, director of the Coalition for Global Hepatitis Elimination at the CDC Taskforce for Global Health, details the need for hepatitis C prevention and treatment options for injection-drug users.